Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible ...

Carruthers was diagnosed with multiple myeloma, a cancer of the blood ... They typically begin in the bone marrow. Bone marrow transplants are used to treat common blood cancers, such as leukemia ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Researchers from the School of Engineering and Applied Science and the Perelman School of Medicine, along with the Children's ...

Bone marrow transplant is associated with accelerated brain aging and worse neurocognitive functioning, data suggest.

As time progressed, new drug therapies (as well as stem-cell transplant treatment ... is the primary bodily system impacted by multiple myeloma. Bone marrow is a spongy, soft tissue with the ...

Opens in a new tab or window Daratumumab plus a standard triplet improved minimal residual disease negativity rates in patients with transplant-ineligible multiple myeloma. The quadruplet also ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...